The EU Commission intends to revise European pharmaceutical legislation at the end of 2022. Even during the consultations at the end of 2021, the pharmaceutical industry did not see any fundamental need for improvement. However, now, it is taking the plunge and presenting its own proposals to make access to medicines faster and fairer for millions of patients in the EU.
By Eugenie Ankowitsch
The EU Commission is still wrestling with a legal framework for the European Health Data Space. In this hot phase, the experts of the TEHDAS Joint Action are publishing one report after another to support the Commission in its efforts. In doing so, they advocate for one point of contact for health data per member state.
By Eugenie Ankowitsch
The legislative package to create a European Health Union was the EU's response to the COVID-19 pandemic. However, the Health Union Communication stated more broadly that "a strong European Health Union will protect our way of life, our economy, and our society." This raises the question of whether the Health Union should be limited to crisis prevention and management or have a broader public health approach, writes Anne Bucher from the think-tank Bruegel.
By Redaktion Table
The EU Commission's draft regulation for the European Health Data Space (EHDS) is eagerly awaited. It will be the first of its kind within the framework of the European data strategy. A consortium is to start work on a kind of beta version of the EHDS this year.
By Eugenie Ankowitsch
The EU Medical Device Regulation (MDR) has been in force since May 2021. The aim of the MDR is to harmonize the requirements for medical devices throughout Europe and to increase safety. The MedTech industry fully shares this goal, says Marc Pierre Möll from the German Medical Technology Association (BVMed). However, the system is not yet practical.
By Redaktion Table
